We have previously demonstrated significantly increased serum chemerin levels in women with polycystic ovary syndrome (PCOS) [20]; a dysmetabolic state of pro-inflammation in women [21], associated with an increased risk of developing T2DM and cardiovascular disorders [22]. This evidence concerns the gene RARRES2 and polycystic ovary syndrome.